![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Five-Years of Continuous Entecavir for Nucleoside-Naive HBeAg(+) Chronic Hepatitis B: Results from Studies ETV-022/-901
|
|
|
Reported by Jules Levin
13th ISVHLD March 20-24 2009 Wash DC
S Han1, TT Chang2, YC Chao3, SK Yoon4, RG Gish5, H Cheinquer6, GE Kitis7,
H Zhang8 and U Iloeje8
1. Division of Digestive Disease, UCLA School Of Medicine, LA, California, USA; 2. Department of Internal Medicine, National Cheng Kung University Medical
College, Tainan, Taiwan; 3. Neuro-Medical Scientific Center Departments, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan; 4. Kangnam St. Mary's Hospital, Seoul, Korea; 5. Division of Hepatology and Complex GI, California Pacific Medical Center, San Francisco, California, USA; 6. Universidade
Federal Do Rio Grande Do Sul, Porto Alegre, Brazil; 7. Department of Gastroenterology, Georgios Papanikolaou Hospital, Thessaloniki, Greece; 8. Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, USA
![Conclusion-1.gif](../images/032509-1/Conclusion-1.gif)
![Summary-2.gif](../images/032509-1/Summary-2.gif)
![PopStudy-3.gif](../images/032509-1/PopStudy-3.gif)
![AnalEfficary-4.gif](../images/032509-1/AnalEfficary-4.gif)
![Demo-5.gif](../images/032509-1/Demo-5.gif)
![Exposure-6.gif](../images/032509-1/Exposure-6.gif)
![Achieving-7.gif](../images/032509-1/Achieving-7.gif)
![serologic-8.gif](../images/032509-1/serologic-8.gif)
![cumulat-9.gif](../images/032509-1/cumulat-9.gif)
![Tenney-10.gif](../images/032509-1/Tenney-10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|